Filing Details
- Accession Number:
- 0001415889-23-014792
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-03 21:39:06
- Reporting Period:
- 2023-11-01
- Accepted Time:
- 2023-11-03 21:39:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1750284 | Olema Pharmaceuticals Inc. | OLMA | Pharmaceutical Preparations (2834) | 300409740 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1831216 | C. David Myles | C/O Olema Pharmaceuticals, Inc. 780 Brannan St San Francisco CA 94103 | Ch. Discov. & Non-Clin Dev Off | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-11-01 | 6,668 | $15.02 | 565,343 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-11-02 | 3,332 | $15.36 | 562,011 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-11-03 | 541 | $17.51 | 561,470 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 12,831 | Indirect | See Footnote |
| Common Stock | 154,846 | Indirect | See Footnote |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person dated June 20, 2023.
- The weighted average sale price for the transaction reported was $15.02, and the range of prices were between $15.00 and $15.09. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $15.36, and the range of prices were between $15.01 and $15.74. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $17.51, and the range of prices were between $17.50 and $17.53. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- The shares are held by The Myles Family Revocable Inter Vivos Trust, of which the Reporting Person is trustee.
- The shares are held by Myles Properties Inc., of which the Reporting Person is President.
Billionaire Hedge Funds
